Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE : a possible explanation for the lack of efficacy of hrDNase I treatment

Department Of Clinical And Experimental Medicine Section Of Hematology University Of Verona

Department of Clinical and Experimental Medicine, University of Verona

Department of Clinical and Experimental Medicine, University of Verona

Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona

Institute G. Gaslini, Department of Immunology

Department of Clinical and Experimental Medicine, Section of Rheumatology, University of Perugia

Department of Internal Medicine, Section of Clinical Immunology, University of Pisa

Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona

Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona

Institute G. Gaslini, Department of Immunology

Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona

Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona

Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona

Department Of Clinical And Experimental Medicine Section Of Rheumatology University Of Perugia

Department Of Clinical And Experimental Immunology Institute G. Gaslini Largo Girolamo Gaslini

Department Of Clinical And Experimental Immunology Institute G. Gaslini Largo Girolamo Gaslini

Department Of Clinical And Experimental Medicine University Of Verona

Department of Experimental Medicine, University of Genova

Department Of Clinical And Experimental Medicine University Of Verona

Department Of Internal Medicine Section Of Clinical Immunology University Of Pisa

Department Of Experimental Medicine University Of Genova

Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona